Growth Metrics

TELA Bio (TELA) Total Current Liabilities (2018 - 2025)

TELA Bio has reported Total Current Liabilities over the past 8 years, most recently at $18.0 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $18.0 million for Q4 2025, up 15.24% from a year ago — trailing twelve months through Dec 2025 was $18.0 million (up 15.24% YoY), and the annual figure for FY2025 was $18.0 million, up 15.24%.
  • Total Current Liabilities for Q4 2025 was $18.0 million at TELA Bio, up from $17.0 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for TELA hit a ceiling of $19.1 million in Q2 2025 and a floor of $5.6 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $15.1 million (2024), compared with a mean of $13.9 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 117.91% in 2022 and later fell 8.07% in 2024.
  • TELA Bio's Total Current Liabilities stood at $10.6 million in 2021, then increased by 17.29% to $12.4 million in 2022, then skyrocketed by 36.8% to $17.0 million in 2023, then fell by 8.07% to $15.6 million in 2024, then grew by 15.24% to $18.0 million in 2025.
  • The last three reported values for Total Current Liabilities were $18.0 million (Q4 2025), $17.0 million (Q3 2025), and $19.1 million (Q2 2025) per Business Quant data.